Tanisha Carino is a respected senior executive with more than two decades of experience in academia, government, and the private sector. She joined the Milken Institute in January 2018 as executive director of FasterCures, the center devoted to saving lives and improving the medical research system. Throughout her distinguished career, Carino has been at the forefront of collaborative efforts to promote policies, research, and business practices that support the fight against disease and improve the lives of patients. She most recently led the U.S. policy function for GlaxoSmithKline, a U.K.-based global health-care company. Prior to her role at GlaxoSmithKline, she spent more than a decade with Avalere Health, where, among other responsibilities, she founded the Center on Evidence Based Medicine and worked with patients, government, and senior leaders at Fortune 500 companies to maximize opportunities and mitigate challenges related to biomedical research and patient access. Prior to Avalere, Carino worked in the Medicare program to improve access for its beneficiaries and support the development of real-world evidence. Carino serves on the boards of the Alliance for Health Policy, the Medical Device Innovation Consortium, the Institute for Clinical and Economic Review, and Bread for the City. She is also a member of the Drug Information Association’s Patient Group Advisory Council and Women of Impact. Carino holds a B.A. in sociology from Emory University in Atlanta and a Ph.D. in health policy from Johns Hopkins University in Baltimore. She is an associate faculty member at the Johns Hopkins Bloomberg School of Public Health and a Fulbright fellow.